{"changeSha256":"ea4a2b0bb6f57bd48ba131f87663e79953852d7ca9755bac762c586c785cb59b","changedAt":"2026-11-14","changedFields":[{"after":"FDA-approved as Voxzogo under accelerated approval for achondroplasia","before":"U.S. label record","field":"Status"},{"after":"A C-type natriuretic peptide analogue approved by FDA as Voxzogo, under accelerated approval, to increase linear growth in children with achondroplasia whose growth plates are open.","before":"A C-type natriuretic peptide analogue. This profile cites a U.S. label record.","field":"Profile summary"},{"after":"A 52-week randomized, placebo-controlled trial in 121 children described in the label found faster annual growth than with placebo. Continued approval may depend on confirmatory trials of clinical benefit.","before":"The cited DailyMed label identifies Vosoritide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.","field":"Evidence note"},{"after":"dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16, fda-drugs-nda214938-2021-11-19-6bf5863742a4","before":"dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16","field":"Cited source records"},{"after":"U.S. National Library of Medicine [sources: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16]; U.S. Food and Drug Administration [sources: fda-drugs-nda214938-2021-11-19-6bf5863742a4]","before":"U.S. National Library of Medicine [sources: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16]","field":"Named organizations"},{"after":"name: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; aliases: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; category: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; status: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16, fda-drugs-nda214938-2021-11-19-6bf5863742a4; summary: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16, fda-drugs-nda214938-2021-11-19-6bf5863742a4; evidenceNote: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16","before":"name: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; aliases: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; category: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; status: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; summary: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16; evidenceNote: dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/vosoritide/versions/3/","version":3},"id":"profile:vosoritide:v3","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-status-changed","notice":"We added a plain-language reader guide with cited answers, re-checked the Voxzogo label, and added the Drugs@FDA approval record.","peptideSlugs":["vosoritide"],"previousChangeEvent":{"path":"/corrections/v1/profiles/vosoritide/v2.json","sha256":"95be7536a1826ad3d549825b3523ec38b09915f0f81ec1fded8a6bd5b1346992"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/vosoritide/versions/2/","version":2},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-vosoritide-228e8560-04a4-4bb1-a81f-29531a9e4d27-v16","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"VOXZOGO (vosoritide) kit · SPL version 16 · published 2025-11-26","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=228e8560-04a4-4bb1-a81f-29531a9e4d27&version=16","verifiedAt":"2026-07-22"},{"id":"fda-drugs-nda214938-2021-11-19-6bf5863742a4","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA214938 · original submission status AP · 2021-11-19 · dataset 2026-08-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA214938%22&limit=1","verifiedAt":"2026-08-14"}],"subject":{"slug":"vosoritide","type":"profile"}}
